Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform
SAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) — Singular Genomics Systems, Inc. (Nasdaq:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced groundbreaking new products and capabilities at the Advances of Genome Biology and Technology (AGBT) conference in Orlando, Florida.
Related news for (OMIC)
- Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
- Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
- Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference
- Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference